Relation of sputum colour to bacterial load in acute exacerbations of COPD  by Brusse-Keizer, M.G.J. et al.
Respiratory Medicine (2009) 103, 601e606ava i lab le at www.sc ienced i rec t . com
journa l homepage : www.e lsev ier . com/ loca te / rmedRelation of sputum colour to bacterial load in acute
exacerbations of COPD*M.G.J. Brusse-Keizer a,*, A.J. Grotenhuis a, H.A.M. Kerstjens b,c,
M.C. Telgen a, J. van der Palen a, M.G.R. Hendrix d,
P.D.L.P.M. van der Valk aa Department of Pulmonary Medicine, Medisch Spectrum Twente, P.O Box 50000, 7500 KA, Enschede, the Netherlands
b Department of Pulmonary Medicine, University Medical Center Groningen, P.O Box 30.001, 9700 RB Groningen,
the Netherlands
c University of Groningen, P.O Box 72, 9700 AB Groningen, the Netherlands
d Regional Laboratory of Public Health, P.O Box 377, 7500 AJ Enschede, the Netherlands
Received 8 July 2008; accepted 14 October 2008
Available online 22 November 2008KEYWORDS
COPD;
Sputum colour;
Bacterial load;
Antibiotics* Originality and clinical relevance
treatment in COPD exacerbations is ne
and bacterial load in sputum of COPD
distinction between patients who are
* Corresponding author. Tel.: þ31 53
E-mail address: mbrussekeizer@eu
0954-6111/$ - see front matter ª 200
doi:10.1016/j.rmed.2008.10.012Summary
Background: When COPD patients present with an exacerbation, one cannot verify a bacterial
cause of an exacerbation without time-consuming laboratory analyses. This makes it difficult
to decide up front if antibiotic treatment is needed. Therefore, in clinical practice sputum
colour and purulence are often used.
Objective: To determine whether sputum colour and purulence, assessed by the Stockley
colour chart, correlated with overall bacterial load in COPD patients admitted for an exacer-
bation. To check the robustness of the colour and purulence assessment, we correlated the
changes in these parameters and the corresponding change in bacterial load in sputum over
the first seven days of hospitalisation.
Methods: Twenty-two COPD patients admitted to the hospital for an exacerbation were
included. During the first seven days daily sputum samples were collected.
Results: A very weak association between bacterial load and sputum colour was found. There
was no difference in bacterial load between patients with purulent sputum or not. Also, no
consistent relationship between change in sputum colour and change in bacterial load during
admission was found.of our paper: In clinical practice sputum colour or purulence is often used to decide if antibiotic
eded. This study, however, shows that there is only a very weak association between sputum colour
patients. The distinction between purulent and mucoid sputum at exacerbation is insufficient for
likely to benefit from antibiotic therapy and those who are not.
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602 M.G.J. Brusse-Keizer et al.Conclusions: The very weak association between bacterial load and sputum colour confirms
concerns over the usefulness of the colour chart. The distinction between purulent and mucoid
sputum at exacerbation is insufficient for distinction between patients who are likely to
benefit from antibiotic therapy and those who are not. Complementary studies are needed
to determine which other, easily measurable factors can be used as predictors for an indication
for use of antibiotics; sputum colour is not the one.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
Morbidity and mortality among patients with chronic
obstructive pulmonary disease (COPD) are for an important
part related to acute exacerbations, which occur on
average one to three times a year but much more
frequently in some patients.1,2 Exacerbations are charac-
terised by a heterogeneous aetiology. Recent studies
showed that at least one-third of the exacerbations might
be triggered by viral infections.3e6 Furthermore, bacteria
play an important role in the onset of exacerbations.7
Several studies have shown the presence of potential
pathogenic micro-organisms (PPMs) in approximately 50% of
exacerbations.8,9 On the other hand, these PPMs might also
colonise the airways of COPD patients.
Treatment of exacerbations with antibiotics is usually
empirical. At clinical presentation it is hard to predict and
verify a bacterial cause without time-consuming laboratory
analyses, which makes it difficult to decide up front if
antibiotic treatment is needed.10 According to the GOLD
criteria, patients with an exacerbation who meet the
Anthonisen type I criteria (increase in dyspnoea, sputum
volume and sputum purulence) benefit from antibiotic
treatment.11 However, Van der Valk et al. reported that an
Anthonisen type I exacerbation does not predict a bacterial
origin of an exacerbation and that sputum purulence was
not associated with a bacterial infection.1
Since purulence is subjective and not clearly defined,
the use of colour charts has been suggested. Stockley et al.
designed and validated a sputum colour chart by which
a distinction between purulent and mucoid exacerbations
can be made.12 Also Allegra et al. provided additional
evidence that purulent sputum is associated with bacterial
growth in the airways of patients with moderate to severe
COPD. They, however, recorded that also in mucoid sputum
presence of bacterial growth was very common (78%).13
Results of a study by Soler et al. showed that self-reported
purulence in the sputum predicts the presence of bacteria
at concentrations in the airways of 102 CFU/mL for pro-
tected specimen brush specimens.14
So, contradictory data and opinions about the associa-
tion between sputum purulence and bacterial involvement
in exacerbations result in uncertainty whether to use
sputum purulence as an indicator for antibiotic treatment.
The aim of the present study was to determine whether
sputum colour and purulence, as assessed by the nine-point
Stockley colour chart, correlate with bacterial load in
patients admitted for an exacerbation of COPD. To check
the robustness of the colour and purulence assessment, the
changes in these parameters and the corresponding changein bacterial load in sputum over the first seven days of
hospitalisation were correlated.
Methods
Patients and study design
Patients hospitalised from April 2007 through June 2007 for
an exacerbation of COPD at the in-patient pulmonary
department of Medisch Spectrum Twente in Enschede, the
Netherlands were recruited. This study is part of our COPD
cohort study, the COMIC study. Recruitment criteria were:
1) a clinical diagnosis of COPD as defined by the GOLD
criteria, 2) admitted with signs and symptoms of an exac-
erbation of COPD, defined as an acute negative change
from the baseline, reported by the patient, in dyspnoea
and/or sputum volume and/or colour of sputum (yellowish
or greenish sputum) and/or cough, which warranted addi-
tional treatment of prednisolone with or without antibiotics
by a physician 3) current or former smoker, 4) age 40 years
or over, 5) no pneumonia, defined as an acute respiratory
tract illness associated with radiographic shadowing on
a chest radiograph which was neither pre-existing nor of
any other cause, 6) no maintenance treatment with anti-
biotics, 7) able to produce spontaneous sputum, and 8) no
other medical condition with low survival or a serious
psychiatric morbidity.
All patients included received care according to the
hospital protocol for treatment of COPD exacerbations. The
hospital’s medical ethical committee approved the study.
All patients provided written informed consent.
Baseline characteristics
Demographic andbaseline datawere collected usingmedical
records. Smoking history was determined by the Vlagtwedde
Questionnaire.15 Exacerbation frequency in the preceding
year and courses of antibiotics and prednisolone during the
last four weeks before admission were registered from
pharmacy records. Exacerbation frequencywasestimatedby
counting the number of separate courses of antibiotics or
prednisolone patients used for lung associated illness. Data
onantibiotics andprednisoloneduring thefirst sevenhospital
days were obtained from hospital pharmacy records.
Sputum colour and microbiology
During the first seven days of admission, spontaneously
expectorated sputum samples were collected. Samples
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Immediately after collection, sputum colour was deter-
mined according to the Stockley protocol (BronkoTest,
Heredilab Inc., Salt Lake City, UT, USA).12
A Gram’s stain and quantitative culture were performed
for all collected sputum samples. Additionally, a semi-
quantitative culture was performed for each patient’s first
sputum sample after admission. Bacterial load was defined
as total amount of CFU/mL. Infection was defined by the
presence of PPM in pure culture or as the presence of one or
more PPM in excess (one log or more) to normal microbio-
logical flora in sputum. Bacterial colonisation was defined
as the presence of PPM in culture in equal amount or less
compared to normal microbiologic flora in sputum.1,16
One day after admission a 10 cc blood sample was
obtained. In all sputum and blood samples IL-6, IL-8 and IL-10
were quantified using PeliKine Compact human sandwich
ELISA kits (Sanquin, CLB, Amsterdam, the Netherlands).
C-reactive protein (CRP) level in sputum and blood was
determined using the NycoCard CRP Single Test (Clindia
Diagnosticsª). MPO enzymatic activity in sputum was deter-
mined by colorimetric change in absorbance during a reac-
tion with O-Dianisidine dihydrochloride (SigmaeAldrichª).
Statistical analysis
Baseline characteristics were reported as means  SD for
continuous variables or as numbers with percentages for
categorical variables. Not normally distributed variables
were reported as median with range. For non-parametric
variables we applied a natural logarithm to obtain a normal
distribution. If this was ineffective, variables were dicho-
tomised based on median values.
Linear regression analysis was used to test the relation
between sputum colour and bacterial load. Correlation
coefficients were calculated to identify variables associ-
ated with sputum colour. In case of dichotomous variables
this was performed by t-tests. The a priori list of potential
confounding variables included: IL-6, IL-10 and CRP in
sputum and blood, result of semi-quantitative culture of
the first sputum sample (no colonisation and no infection
versus colonisation or infection), smoking status, use of
antibiotics or prednisolone during the four weeks prior to
admission (yes/no) and use of antibiotics during the first
seven days of admission (yes/no). Variables associated with
sputum colour with p < 0.15 were subsequently tested for
an association with bacterial load and considered as
potential confounders when p < 0.15. Also of the variables
IL-8, MPO in sputum, number of leukocytes in sputum, we
analysed the association with both sputum colour and
bacterial load. Since these variables are in the assumed
pathway they were not entered in the multivariate model.
We started the multivariate model with all potential
confounders. Variables with the highest p-value were
eliminated step by step, and at each step we verified
whether the beta-coefficient of sputum colour had not
changed by 10% or more from its initial value. The inter-
action between sputum colour and antibiotic use during the
four weeks prior to admission and interaction between
sputum colour and use of antibiotics during the first seven
days of admission were assessed by adding these interac-
tion variables into the multivariate model.In a secondary analysis the association between sputum
purulence and bacterial load was tested. Sputum with
a colour value 2 was defined as mucoid and sputum colour
3 was defined as purulent. Potential confounding
variables were identified by an essentially similar approach
as described above, but the formal testing of associations
was now performed with t-tests or ManneWhitney U-tests
as appropriate for continuous variables and by Chi-square
tests or Fisher’s Exact tests as appropriate for between-
group comparisons of categorical variables. The association
of variables in the pathway with sputum purulence and
bacterial load were analysed. Interaction between sputum
purulence and antibiotic use during the four weeks prior to
admission and interaction between sputum purulence and
use of antibiotics during the first seven days of admission
were assessed by adding these interaction variables into
the multivariate model.
Repeated measurements analysis was performed to test
for change in sputum colour and bacterial load during the
first seven days of admission. Finally, we looked at the
relationship between a change in sputum colour and
a change in bacterial load during hospital admission by
means of scatter plots and correlation coefficients.
Data-analysis was performed with the statistical
package SPSS/PC for Windows (version 12.0.1) (SPSS, Inc.,
Chicago, IL).
Results
Table 1 shows the baseline characteristics of the 22
included patients. In total, 124 sputum samples were
obtained.
Relationship between sputum colour and
bacterial load
The univariate linear regression analysis showed no signifi-
cant relation between sputum colour and bacterial load
(p Z 0.16). Variables univariately associated with sputum
colour were: IL-8 in sputum, MPO in sputum, leucocytes in
sputum (yes/no), CRP in blood (14 versus >14 mg/L), use
of antibiotics during the first seven days of admission and
result of semi-quantitative culture of the first sputum
sample. Of these variables, IL-8 in sputum, MPO in sputum
and use of antibiotics during the first seven days of
admission were also associated with bacterial load. The
association between bacterial load and sputum colour was
only adjusted for the use of antibiotics, since IL-8 and MPO
are part of the assumed pathway between bacterial load
and sputum colour, and adjustment for these factors would
make a potential relationship disappear. There was no
interaction between sputum colour and antibiotic use
during the four weeks prior to admission, nor was there an
interaction between sputum colour and use of antibiotics
during the first seven days of admission. The multivariate
model showed a significant positive regression coefficient
for sputum colour (0.41 (95% CI: 0.01e0.81; pZ 0.045)) and
a significant negative coefficient for antibiotic use during
admission (2.19 (95% CI: 3.67 to 0.71; p Z 0.004)).
Both regression coefficients are on a log base. The
explained variance of this model was only 0.087.
Table 1 Baseline characteristics of participating COPD
patients.
N Z 22
Mean age at enrolment in years (SD) 68 (10)
Gender (Number (%))
Male 10 (45)
Female 12 (55)
Smoking status (Number (%))
Current smokers 12 (55)
Ex-smokers 10 (45)
Median exacerbation frequency/year
(range)a
1.5 (0e5)
GOLD classification (Number (%))
GOLD stage 1 1 (5)
GOLD stage 2 5 (23)
GOLD stage 3 10 (45)
GOLD stage 4 6 (27)
Lung function (post-bronchodilator)
Median FEV1 in litres (range) 0.95 (0.43e2.97)
Median FEV1 as % of predicted (range) 36 (19e83)
Mean FEV1/VC in % (SD) 40 (13)
Previous treatment (Number (%))
Antibiotics <4 weeks before study entry 15 (68)
Finished course of antibiotics
before admission
10 (45)
Still receiving antibiotics at admission 5 (23)
Prednisolone <4 weeks before
study entry
14 (64)
Finished course of prednisolone
before admission
11 (50)
Still receiving prednisolone
at admission
3 (14)
Prednisolone maintenance therapy 2 (9.1)
FEV1Z Forced Expiratory Volume in 1 s; IVCZ Inspiratory Vital
Capacity; GOLD Z Global Initiative on Obstructive Lung
Disease.
a Exacerbation frequency refers to the number of exacerba-
tions during the year preceding admission and is based on the
number of separate courses of antibiotics or prednisolone
prescribed for lung associated illness according to the database
of the patients’ pharmacy.
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The univariate linear regression analysis showed no signifi-
cant relationship between sputum purulence and bacterial
load (p Z 0.64). Variables univariately associated with
sputum purulence were: IL-8 in sputum, MPO in sputum and
leucocytes in sputum (yes/no). IL-8 in sputum and MPO in
sputum were also associated with bacterial load. Since, IL-8
and MPO are both part of the assumed pathway between
bacterial load and sputum purulence, these variables were
again not included in the multivariate analysis and no
potential confounders remained. Furthermore there was no
interaction between sputum purulence and antibiotic use
during the four weeks prior to admission, nor was thereinteraction between sputum purulence and use of antibi-
otics during the first seven days of admission.
Longitudinal change in sputum colour and
bacterial load during admission
Repeated measurements analysis showed no change in
sputum colour (p Z 0.16) and bacterial load (p Z 0.99)
during the first seven days of admission. Fig. 1 shows the
mean value of sputum colour and bacterial load at days 2, 4
and 6 of admission. Fig. 2 a and b shows respectively the
change in colour and the change in bacterial load during the
first seven days of admission on a patient level.
Relationship between change in sputum colour
and change in bacterial load
There was no consistent relationship between change in
sputum colour and change in bacterial load during admis-
sion, as judged by the constructed scatter plots and
correlation coefficients comparing baseline data with
follow-up days and between consecutive follow-up days.
The correlation coefficients varied from 0.819 to 0.884.
Discussion
This study found a significant but very weak association
between bacterial load and sputum colour after correction
for confounding by antibiotic use during admission. Only
8.7% of the variance in bacterial load could be explained by
this model. Furthermore when we dichotomised the nine-
point score of sputum colour into purulent and mucoid
sputum, the relationship with bacterial load vanished
completely. Also, no consistent relationship between
change in sputum colour and change in bacterial load
during admission was found.
Our findings on the relationship between sputum colour
and purulence with bacterial load are in contrast to the
results of other study groups. Stockley et al. showed that
the presence of purulent sputum was 94.4% sensitive and
77.0% specific for the yield of a high bacterial load. Soler
et al., who looked at the self-reported presence of purulent
sputum, concluded that the self-reported presence of
purulent sputum predicted the presence of bacterial
infection in the distal airways.14 Allegra et al. found an
association between purulent sputum and bacterial growth,
in which growth was classified as the presence of >106 CFU/
mL.13 They, however, did not only found a high number of
positive cultures in purulent sputum samples (95%), but also
in mucoid sputum samples (78%). So, although they
conclude that purulent sputum was associated with
bacterial growth, the distinction between purulent and
mucoid sputum was not sufficient for the distinction
between bacterial growth or not.
There are some differences that possibly could explain
some of the contradictory results. One explanation might
be that contrary to the abovementioned studies, we looked
at total bacterial load on a continuous scale and not
classified into bacterial growth or not, or infection or not.
Another difference is that in the studies by Stockley,
Allegra and Soler, patients had not received antibiotic
Figure 1 Longitudinal change in mean value (with error bars) of sputum colour and bacterial load during admission.
Relation of sputum colour to bacterial load 605treatment 4 weeks before admission. In our study 68% of
the patients received antibiotics 4 weeks prior to the study
and 23% received antibiotics at admission. The decision not
to exclude these patients was based on the fact that if we
want to use sputum colour as an indication for antibiotic
treatment, it should be usable in clinical practice. And as in
our study, many patients already receive antibiotics from
their GP or chest physician before admission. By performing
multivariate analyses, correcting for the use of antibiotics
we addressed this item.
Another difference is that Allegra et al. developed their
own colour-coding chart, which might have introduced some
differences in coding the colour of the sputum samples.Figure 2 a. Longitudinal change of sputum colour during admissi
during admission on a patient level.Like in our study, Stockley et al. also looked at changes
in sputum colour over time. However, they compared
sputum samples during exacerbations and during stable
state after 2 months. They showed that sputum colour of
patients with mucoid exacerbations remained similar. On
the other hand, in patients presenting with purulent
sputum, colour changed from a median of 4.0 to a median
of 3.0 in stable state. This indicates that many patients do
not return to mucoid sputum, which would implicate that
these patients would be treated again with antibiotics
during their next exacerbation. If one believes in the value
of sputum colour determination, this maintenance of
purulent sputum should elicit different/longer/higher doseon on a patient level. b. Longitudinal change of bacterial load
606 M.G.J. Brusse-Keizer et al.antibiotics. We, however, observed absolutely no change in
both mean sputum colour and mean bacterial load on
a group level over the first seven days of admission,
although the majority of patients was treated with antibi-
otics. This might implicate that change in sputum colour
takes a long time, and also bacterial load does not seem to
be immediately changed by a course of antibiotics. Within-
patient changes were, however, often present, but changes
were in all directions, and varied from day to day.
Furthermore, there appeared to be no consistent relation-
ship between the individual changes in sputum colour and
the accompanied change in bacterial load. This makes us
reluctant about the usefulness of sputum colour as indi-
cator for bacterial load and therefore for treatment with
antibiotics.
The current study showed that there is only a very weak
association between bacterial load and sputum colour,
which confirms the results of a previous study performed by
our study group1 and that of others. Furthermore when
sputum colour was divided into purulent and mucoid
sputum, the relationship with bacterial load vanished
completely. The distinction between purulent and mucoid
sputum at the moment patients present themselves with an
exacerbation seems therefore insufficient for distinction
between patients who are likely to benefit form antibiotic
therapy and those who are not. More studies are needed to
determine which easy measurable factors could be used as
a predictor for an indication for use of antibiotics; sputum
colour is not the one.Co
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